Univariate analysis of hospitalized patients. by Jie Zhao (49409)

Subjects:

The red blood cell-platelet ratio affects prognosis. by Jie Zhao (49409)

Subjects:

Red blood cell-platelet ratio and HR-restriction cube diagram during hospitalization. by Jie Zhao (49409)

Subjects:

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization. by Jie Zhao (49409)

Subjects:

Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM. by Jie Zhao (49409)

Subjects:

Clinical baseline data. by Jie Zhao (49409)

Subjects:

Univariate analysis of ICU patients. by Jie Zhao (49409)

Subjects:

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay. by Jie Zhao (49409)

Subjects:

Impact of red blood cell-platelet ratio trajectories in the first four days before ICU admission on prognosis and clinical outcomes in the validation set. by Jie Zhao (49409)

Subjects:

Clinical baseline data after PSM. by Jie Zhao (49409)

Subjects:

Impact of red blood cell-platelet ratio trajectories on prognosis and clinical outcomes in the first four days before ICU admission in the training set. by Jie Zhao (49409)

Subjects:

International Classification of Diseases Codes. by Jie Zhao (49409)

Subjects:

Baseline data of clinical ICU patients. by Jie Zhao (49409)

Subjects:

The significant decrease in GLT-1 levels observed in the nucleus accumbens of rats that had consumed morphine for fifty-six days was completely reversed by the co-administration of NAC (40 mg/kg/day, i.p.) and ibudilast (7.5 mg/kg/day, i.p.). by María Elena Quintanilla (8068691)

Clinical characteristics of the study population. by Hun Gi Lee (21526538)

Subjects:

Cat Stress Score (CSS) was significantly predicted by intake type and days in the study. by Allison Andrukonis (11846404)

eQTL analysis of significant SNPs. by Dai Nogimura (21445649)

Subjects:

Significant associations in the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P_i‐induced VSMCs. …”

All DEGs in wild-type and <i>atb’’αβγδ</i> plants. by Hyuk Sung Yoon (20208672)

Subjects: